MYOV

Myovant Sciences Ltd. MYOV

Trading inactive

Bénéficiaire Individuel

Déclarant Citoyenneté ou lieu d'organisation Pouvoir de vote unique Pouvoir de vote partagé Pouvoir de disposition unique Pouvoir de disposition partagé Montant en propriété effective Pourcentage détenu Date d'achat
Alpine Global Management, LLC1 Delaware, USA 6425084 0 6425084 0 6425084 6.6 % 17/02/2023
Alpine Global Management, LLC1 Delaware, USA 6425084 0 6425084 0 6425084 6.6 % 17/02/2023
BB Biotech AG Switzerland 0 5872639 0 5872639 5872639 6 % 14/02/2023
Biotech Target N.V. Curacao 0 5872639 0 5872639 5872639 6 % 14/02/2023
Biotech Target N.V. Curacao 0 5872639 0 5872639 5872639 6 % 14/02/2023
BB Biotech AG Switzerland 0 5872639 0 5872639 5872639 6 % 14/02/2023
Peter Kolchinsky United States 0 0 0 0 0 0 % 14/02/2020
Rajeev Shah United States 0 0 0 0 0 0 % 14/02/2020
RA Capital Management, L.P. Delaware 0 0 0 0 0 0 % 14/02/2020
N/A Curacao 0 4815109 0 4815109 4815109 5.4 % 14/02/2020
N/A Curacao 0 4815109 0 4815109 4815109 5.4 % 14/02/2020
BB Biotech AG Switzerland 0 4815109 0 4815109 4815109 5.4 % 14/02/2020
BB Biotech AG Switzerland 0 4815109 0 4815109 4815109 5.4 % 14/02/2020
Takeda Pharmaceutical Company Limited Japan 0 3920625 0 3920625 3920625 4.37 % 24/01/2020
Millennium Pharmaceuticals, Inc. United States 0 3920625 0 3920625 3920625 4.37 % 24/01/2020
Takeda Pharmaceuticals International AG Switzerland 0 7420625 0 7420625 7420625 10.83 % 24/01/2020
Peter Kolchinsky United States 0 3711549 0 3711549 3711549 5.4 % 14/02/2019
RA Capital Management, LLC Massachusetts 0 3711549 0 3711549 3711549 5.4 % 14/02/2019
QVT Family Office Fund LP Cayman Islands 0 0 0 38341357 38341357 54.1 % 14/02/2019
QVT Financial LP Delaware 0 0 0 38341357 38341357 54.1 % 14/02/2019
QVT Financial GP LLC Delaware 0 0 0 38341357 38341357 54.1 % 14/02/2019
QVT Associates GP LLC Delaware 0 0 0 38341357 38341357 54.1 % 14/02/2019
Dexxon Holdings Ltd. Israel 0 0 0 38341357 38341357 54.1 % 14/02/2019
Dexxon Holdings Ltd. Israel 0 0 0 38341357 38341357 54.1 % 14/02/2019
Dexcel Pharma Technologies Ltd. Israel 0 0 0 38341357 38341357 54.1 % 14/02/2019
Dan Oren Israel 0 0 0 38341357 38341357 54.1 % 14/02/2019
Dan Oren Israel 0 0 0 38341357 38341357 54.1 % 14/02/2019
Dexcel Pharma Technologies Ltd. Israel 0 0 0 38341357 38341357 54.1 % 14/02/2019
Patrick Machado 38341357 54.1 % 13/02/2019
Roivant Sciences Ltd. Bermuda 38341357 0 38341357 0 38341357 54.1 % 13/02/2019
Viking Global Opportunities GP LLC Delaware 0 0 0 38341357 38341357 0 % 10/01/2019
O. Andreas Halvorsen Norway 0 0 0 38341357 38341357 0 % 10/01/2019
Viking Global Investors LP Delaware 0 0 0 38341357 38341357 0 % 10/01/2019
Viking Global Performance LLC Delaware 0 0 0 38341357 38341357 0 % 10/01/2019
Viking Global Equities LP Delaware 0 0 0 0 0 0 % 10/01/2019
Viking Global Equities II LP Delaware 0 0 0 38341357 38341357 0 % 10/01/2019
VGE III Portfolio Ltd. Cayman Islands 0 0 0 0 0 0 % 10/01/2019
Viking Global Equities Master Ltd. Cayman Islands 0 0 0 38341357 38341357 0 % 10/01/2019
Viking Long Fund GP LLC Delaware 0 0 0 38341357 38341357 0 % 10/01/2019
Viking Long Fund Master Ltd. Cayman Islands 0 0 0 38341357 38341357 0 % 10/01/2019
Viking Global Opportunities GP LLC Delaware 0 0 0 38341357 38341357 0 % 10/01/2019
Viking Global Opportunities Portfolio GP LLC Delaware 0 0 0 38341357 38341357 0 % 10/01/2019
Viking Global Opportunities Illiquid Investments LP Cayman Islands 0 0 0 38341357 38341357 0 % 10/01/2019
David C. Ott United States 0 0 0 38341357 38341357 0 % 10/01/2019
Rose S. Shabet United States 0 0 0 38341357 38341357 0 % 10/01/2019
Viking Global Investors LP Delaware 0 0 0 38341357 38341357 0 % 10/01/2019
Viking Global Performance LLC Delaware 0 0 0 38341357 38341357 0 % 10/01/2019
Viking Global Equities LP Delaware 0 0 0 0 0 0 % 10/01/2019
Viking Global Equities II LP Delaware 0 0 0 38341357 38341357 0 % 10/01/2019
VGE III Portfolio Ltd. Cayman Islands 0 0 0 0 0 0 % 10/01/2019
Viking Global Equities Master Ltd. Cayman Islands 0 0 0 38341357 38341357 0 % 10/01/2019
Viking Long Fund GP LLC Delaware 0 0 0 38341357 38341357 0 % 10/01/2019
Viking Long Fund Master Ltd. Cayman Islands 0 0 0 38341357 38341357 0 % 10/01/2019
Viking Global Opportunities Portfolio GP LLC Delaware 0 0 0 38341357 38341357 0 % 10/01/2019
Viking Global Opportunities Illiquid Investments LP Cayman Islands 0 0 0 38341357 38341357 0 % 10/01/2019
O. Andreas Halvorsen Norway 0 0 0 38341357 38341357 0 % 10/01/2019
David C. Ott United States 0 0 0 38341357 38341357 0 % 10/01/2019
Rose S. Shabet United States 0 0 0 38341357 38341357 0 % 10/01/2019
Takeda A/S Denmark 0 7420625 0 7420625 7420625 12.2 % 29/03/2018
Takeda Pharmaceuticals U.S.A., Inc. United States America 0 7420625 0 7420625 7420625 12.2 % 29/03/2018
Takeda Pharmaceuticals International AG Switzerland 0 7420625 0 7420625 7420625 12.2 % 29/03/2018
Millennium Pharmaceuticals, Inc. United States America 0 7420625 0 7420625 7420625 12.2 % 29/03/2018
Takeda Pharmaceutical Company Limited Japan 0 7420625 0 7420625 7420625 12.2 % 29/03/2018
Takeda Pharma A/S Denmark 0 7420625 0 7420625 7420625 12.2 % 29/03/2018
Takeda Europe Holdings B.V. Nerlands 0 7420625 0 7420625 7420625 12.2 % 29/03/2018
VGE III Portfolio Ltd. _____________________________________________________________________________ Cayman Islands 0 0 37231342 37231342 61 % 14/02/2018
Viking Long Fund GP LLC _____________________________________________________________________________ Delaware 0 0 37231342 37231342 61 % 14/02/2018
Viking Long Fund Master Ltd. _____________________________________________________________________________ Cayman Islands 0 0 37231342 37231342 61 % 14/02/2018
Viking Global Opportunities GP LLC _____________________________________________________________________________ Delaware 0 0 37231342 37231342 61 % 14/02/2018
Viking Global Opportunities Portfolio GP LLC _____________________________________________________________________________ Delaware 0 0 37231342 37231342 61 % 14/02/2018
Viking Global Opportunities Illiquid Investments LP _____________________________________________________________________________ Cayman Islands 0 0 37231342 37231342 61 % 14/02/2018
O. Andreas Halvorsen _____________________________________________________________________________ Norway 0 0 37231342 37231342 61 % 14/02/2018
David C. Ott _____________________________________________________________________________ United States 0 0 37231342 37231342 61 % 14/02/2018
Rose S. Shabet _____________________________________________________________________________ United States 0 0 37231342 37231342 61 % 14/02/2018
Viking Global Investors LP _____________________________________________________________________________ Delaware 0 0 37231342 37231342 61 % 14/02/2018
Viking Global Performance LLC _____________________________________________________________________________ Delaware 0 0 37231342 37231342 61 % 14/02/2018
Viking Global Equities LP _____________________________________________________________________________ Delaware 0 0 37231342 37231342 61 % 14/02/2018
Viking Global Equities II LP _____________________________________________________________________________ Delaware 0 0 37231342 37231342 61 % 14/02/2018
Takeda Pharmaceuticals International AG Switzerland 0 7390530 0 7390530 7390530 12.3 % 06/03/2017
Dan Oren Israel 0 0 0 37231342 37231342 61.8 % 13/02/2017
Dexxon Holdings Ltd. Israel 0 0 0 37231342 37231342 61.8 % 13/02/2017
Dan Oren Israel 0 0 0 37231342 37231342 61.8 % 13/02/2017
Dexxon Holdings Ltd. Israel 0 0 0 37231342 37231342 61.8 % 13/02/2017
VGE III Portfolio Ltd. _____________________________________________________________________________ Cayman Islands 0 0 37231342 37231342 61.8 % 10/02/2017
Viking Long Fund GP LLC _____________________________________________________________________________ Delaware 0 0 37231342 37231342 61.8 % 10/02/2017
Viking Global Opportunities GP LLC _____________________________________________________________________________ Delaware 0 0 37231342 37231342 61.8 % 10/02/2017
Viking Global Opportunities Portfolio GP LLC _____________________________________________________________________________ Delaware 0 0 37231342 37231342 61.8 % 10/02/2017
Viking Global Opportunities Illiquid Investments LP _____________________________________________________________________________ Cayman Islands 0 0 37231342 37231342 61.8 % 10/02/2017
O. Andreas Halvorsen _____________________________________________________________________________ Norway 0 0 37231342 37231342 61.8 % 10/02/2017
David C. Ott _____________________________________________________________________________ United States 0 0 37231342 37231342 61.8 % 10/02/2017
Daniel S. Sundheim _____________________________________________________________________________ United States 0 0 37231342 37231342 61.8 % 10/02/2017
Viking Long Fund Master Ltd. _____________________________________________________________________________ Cayman Islands 0 0 37231342 37231342 61.8 % 10/02/2017
Viking Global Investors LP _____________________________________________________________________________ Delaware 0 0 37231342 37231342 61.8 % 10/02/2017
Viking Global Performance LLC _____________________________________________________________________________ Delaware 0 0 37231342 37231342 61.8 % 10/02/2017
Viking Global Equities LP _____________________________________________________________________________ Delaware 0 0 37231342 37231342 61.8 % 10/02/2017
Viking Global Equities II LP _____________________________________________________________________________ Delaware 0 0 37231342 37231342 61.8 % 10/02/2017
QVT Fund V LP Cayman Islands 0 0 0 37231342 37231342 61.8 % 10/02/2017
QVT Associates GP LLC Delaware 0 0 0 37231342 37231342 61.8 % 10/02/2017
QVT Financial GP LLC Delaware 0 0 0 37231342 37231342 61.8 % 10/02/2017
QVT Financial LP Delaware 0 0 0 37231342 37231342 61.8 % 10/02/2017
Viking Global Opportunities Illiquid Investments LP _____________________________________________________________________________ Cayman Islands 37231342 0 37231342 37231342 61.8 % 10/02/2017
Viking Global Investors LP _____________________________________________________________________________ Delaware 37231342 0 37231342 37231342 61.8 % 10/02/2017
Viking Global Performance LLC _____________________________________________________________________________ Delaware 37231342 0 37231342 37231342 61.8 % 10/02/2017
Viking Global Equities LP _____________________________________________________________________________ Delaware 37231342 0 37231342 37231342 61.8 % 10/02/2017
Viking Global Equities II LP _____________________________________________________________________________ Delaware 37231342 0 37231342 37231342 61.8 % 10/02/2017
VGE III Portfolio Ltd. _____________________________________________________________________________ Cayman Islands 37231342 0 37231342 37231342 61.8 % 10/02/2017
Viking Long Fund GP LLC _____________________________________________________________________________ Delaware 37231342 0 37231342 37231342 61.8 % 10/02/2017
Viking Long Fund Master Ltd. _____________________________________________________________________________ Cayman Islands 37231342 0 37231342 37231342 61.8 % 10/02/2017
Viking Global Opportunities GP LLC _____________________________________________________________________________ Delaware 37231342 0 37231342 37231342 61.8 % 10/02/2017
Viking Global Opportunities Portfolio GP LLC _____________________________________________________________________________ Delaware 37231342 0 37231342 37231342 61.8 % 10/02/2017
O. Andreas Halvorsen _____________________________________________________________________________ Norway 37231342 0 37231342 37231342 61.8 % 10/02/2017
David C. Ott _____________________________________________________________________________ United States 37231342 0 37231342 37231342 61.8 % 10/02/2017
Daniel S. Sundheim _____________________________________________________________________________ United States 37231342 0 37231342 37231342 61.8 % 10/02/2017
Andrew Lo 37231342 61.8 % 10/02/2017
QVT Fund V LP Cayman Islands 0 37231342 0 37231342 37231342 61.8 % 10/02/2017
QVT Financial LP Delaware 0 37231342 0 37231342 37231342 61.8 % 10/02/2017
QVT Financial GP LLC Delaware 0 37231342 0 37231342 37231342 61.8 % 10/02/2017
QVT Associates GP LLC Delaware 0 37231342 0 37231342 37231342 61.8 % 10/02/2017
QVT Financial LP Delaware 0 37231342 0 37231342 37231342 61.8 % 10/02/2017
QVT Fund V LP Cayman Islands 0 37231342 0 37231342 37231342 61.8 % 10/02/2017
QVT Associates GP LLC Delaware 0 37231342 0 37231342 37231342 61.8 % 10/02/2017
QVT Financial GP LLC Delaware 0 37231342 0 37231342 37231342 61.8 % 10/02/2017
Roivant Sciences Ltd. 37231342 61.8 % 10/02/2017
Patrick Machado 37231342 61.8 % 10/02/2017
BB Biotech AG Switzerland 0 3086929 0 3086929 3086929 5.1 % 28/12/2016
N/A Curacao 0 3086929 0 3086929 3086929 5.1 % 28/12/2016
BB Biotech AG Switzerland 0 3086929 0 3086929 3086929 5.1 % 28/12/2016
N/A Curacao 0 3086929 0 3086929 3086929 5.1 % 28/12/2016

Senat trading

Bureau Date de la transaction Date de réception Type Montant Commentaire

Senat Divulgation

Représentant Date de la transaction Date de divulgation Type Montant District